ACLY and obesity due to melanocortin 4 receptor deficiency: ACLY also fuels cancer5 and vascular smooth muscle proliferation,6 and its in vivo inhibition is being pursued as a potential therapy for pulmonary hypertension and coronary vascular disease,6 obesity and ectopic lipid accumulation in diabetic kidney disease,7 and cancer.8